The European Medicines Agency said on Friday that current stocks of Baxter International’s peritoneal dialysis solutions should be replaced because of the possibility of contamination. The regulator was informed by Baxter of the potential presence of endotoxins in Dianeal, Extraneal and Nutrineal — three sterile solutions used in patients who have to undergo dialysis because of kidney failure. Get the full story »
Inside these posts: Dialysis
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
